Triathlon Medical Venture Partners
Triathlon Medical Venture Partners, a Midwest-based venture capital firm, finances life sciences companies.
Business Model:
Revenue: $6.6M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Triathlon Medical Venture Partners Information
Geographic Data
Address: P O Box 42862
City: Cincinnati
State: OH
Zip: 45242
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Triathlon Medical Venture Partners is a venture capital company that offers private equity investment services to firms in the biopharmaceutical and medical device industries. It was founded in 2004 by Dennis Costello and John Rice and is based in Ohio.
Contact Phone:
+15135706238
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2005 | Remon Medical Technologies | Series C | 0 |
| 3/2009 | BioVex | Venture Round | 40M |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 6/2010 | Tolera Therapeutics | Series B | 4.1M |
| 4/2006 | Mitralign | Series B | 3.3M |
| 1/2007 | Hydrocision | Series G | 12.7M |
| 6/2007 | Alluxa | Venture Round | 1.5M |
| 6/2008 | Tolera Therapeutics | Series A | - |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 4/2014 | Alluxa | Venture Round | 0 |
| 1/2006 | CoLucid Pharmaceuticals | Series A | 0 |
| 10/2012 | Tolera Therapeutics | Series B | 0 |
| 11/2007 | BioVex | Series E | 35M |
| 4/2011 | Akebia Therapeutics | Series B | 0 |
| 10/2008 | Juventas Therapeutics | Series A | 7.7M |
| 1/2008 | CS-Keys | Series A | 6.3M |
| 7/2009 | Akebia Therapeutics | Series A | 25M |
| 7/2008 | Celleration | Series D | 0 |
| 1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
| 8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
| 7/2008 | CoLucid Pharmaceuticals | Series B | 0 |
| 12/2006 | Hydrocision | Series G | 12.7M |
| 1/2010 | Endocyte | Series C | 26M |
| 4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
| 1/2011 | Celleration | Series E | 0 |
| 6/2006 | Mitralign | Series B | 13M |
| 5/2012 | Mitralign | Series D | 0 |
| 9/2005 | Kereos | Series B | 0 |
| 12/2007 | Mitralign | Series C | 0 |
| 7/2012 | Juventas Therapeutics | Series B | 0 |
| 11/2006 | Endocyte | Venture Round | 30M |
| 3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
| 3/2007 | Endocyte | Series C | 15M |
| 1/2008 | Hydrocision | Series H | 4.8M |
| 3/2005 | Renal Solutions | Series B | 16.5M |
| 3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
| 1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
| 4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
| 4/2014 | Alluxa | Venture Round | 0 |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 10/2012 | Tolera Therapeutics | Series B | 0 |
| 7/2012 | Juventas Therapeutics | Series B | 0 |
| 5/2012 | Mitralign | Series D | 0 |
| 8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
